Interference in immunoassay

Annals of Clinical Biochemistry

Volumn 36, Issue 6, 1999, Pages 704-721

  Selby, Colin ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Heterophilic antibodies; Hook effects; Matrix effects; Specificity

Indexed keywords

HETEROPHILE ANTIBODY; HORMONE BINDING PROTEIN; PROTEIN; REAGENT; THYROID ANTIBODY;

BLOOD SAMPLING; IMMUNOASSAY; PRIORITY JOURNAL; REVIEW;

EID: 0032753840     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329903600603     Document Type: Review

References (120)

1. Nahm MH, Hoffmann JW. Heteroantibody: phantom of the immunoassay. Clin Chem 1990; 36: 829
2. Sgouris JT. Limitations of the radioimmunoassay for hepatitis B antigen. N Engl J Med 1973; 288: 160-1
3. Kroll MH, Elin RJ. Interference with clinical laboratory analyses. Clin Chem 1994; 40: 1996-2005
4. Chapman RS. Interference in immunoassay. Commun Lab Med 1992; 3: 49-55
5. Gosling JP. A decade of immunoassay development. Clin Chem 1990; 36: 1408-27
6. Baudner S. Measurement signal versus value in immunoassays for human plasma proteins. Scand J Clin Lab Invest Suppl 1991; 205: 70-8
7. Anonymous. IFCC provisional recommendation on quality control in clinical chemistry. J Clin Chem Biochem 1976; 14: 270
8. Keffer JH. Preanalytical considerations in thyroid function testing. Clin Chem 1996; 42: 125-34
9. Cuckle HS, Wald NJ, Densem JW, Royston P. The affect of smoking in pregnancy on maternal alphafetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels. Br J Obstet Gynaecol 1991; 97: 1160-2
10. Butler J. Negative interference in immunoassays [Letter]. Clin Chem 1995; 41: 481-2
11. Seth J, Sturgeon C, Ellis A. Annual Report of the UK NEQAS for Peptide Hormones 1995. Edinburgh: UK NEQAS for Peptide Hormones, 1995
12. Wood PJ, Donovan SJ, Chamberlain A. The influence of blood collection tube types on Immulite endocrine analyser results. In: Proceedings of the ACB National Meeting, Birmingham, UK, 1997; Abstract 54
13. Nelson JC, Wilcox RB, Pandian MR. Dependence of free thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine binding proteins. Clin Chem 1992; 38: 1294-300
14. Bowie LJ, Kirkpatrick PB, Dohnal JC. Thyroid function testing with the TDx: interference from endogenous fluophores. Clin Chem 1987; 33: 1467
15. Bloom JN, Herman DC, Elin RJ, Silva CA, Ruddel ME, Nussenblat RB. Intravenous fluorescein interference with clinical laboratory tests. Am J Ophthalmol 1989; 108: 375-9
16. Weber TH, Kapyaho KI, Tanner P. Endogenous interference in immunoassays in clinical chemistry. A review. Scand J Clin Lab Invest Suppl 1990; 201: 77-82
17. Selby C, Barker GA, Lawson N. The stability of seven commonly measured analytes in stored whole blood. In: Proceedings of the UK NEQAS Endocrinology Meeting, Cardiff, 1996: Abstract 13
18. Diver MJ, Hughes JG, Hutton JL, West CR, Hipkin LJ. The long term stability in whole blood of 14 commonly-requested hormone analytes. Ann Clin Biochem 1994; 31: 561-5
19. Hammer EJ, Astley JP. Increase in serum testosterone following contact with blood cells. Ann Clin Biochem 1985; 22: 539-40
20. Wood WG. Matrix effects in immunoassays. Scand J Clin Lab Invest Suppl 1991; 205: 105-12
21. Hashida S, Nakagawa K, Imagawa M, Inoue S, Yoshitake S, Ishikawa E, et al. Use of inorganic salts to minimise serum interference in a sandwich enzyme assay for growth hormone using Fab' horse radish peroxidase conjugate. Clin Chim Acta 1983; 135: 263-73
22. 125I radiolabel. Clin Chem 1982; 28: 1314-8
23. 2 fragments. Immunol Commun 1984; 13: 15-27
24. Labelling of protein antigens. In: Hunter WM, Corrie JET, eds. Immunoassays for Clinical Chemistry. Edinburgh: Churchill Livingstone, 1983: 263-315
25. 125I) labelling. In: Radioimmunoassay Theory and Practice. A Handbook for Laboratory Personnel. Konstanz: Schnetztor Verlag, 1981: 95-114
26. Requirements for separation methods in immunoassay. In: Hunter WM, Corrie JET, eds. Immunoassays for Clinical Chemistry. Edinburgh: Churchill Livingstone, 1983: 135-207
27. Edwards R. The development and use of PEG assisted second antibody as a separation technique in radioimmunoassay. In: Hunter WM, Corrie JET, eds. Immunoassays for Clinical Chemistry. Edinburgh: Churchill Livingstone, 1983: 139-46
28. Forrest GC, Rattle SJ. Magnetic particle radioimmunoassay. In: Hunter WM, Corrie JET, eds. Immunoassays for Clinical Chemistry. Edinburgh: Churchill Livingstone, 1983; 147-62
29. Stockigt JR, Stevens V, White EL, Barlow JW. 'Unbound analog' radioimmunoassays for free thyroxine measure the albumin bound hormone fraction. Clin Chem 1983; 29: 1408-10
30. Kennedy DM, Selby C, Lawson N. Measurement of urinary free cortisol using the ACS:180 serum cortisol assay. Proceedings of the XVI International Congress of Clinical Chemistry, London, 1996: 460
31. Nelson JC, Weiss RM, Wilcox RB. Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays. J Clin Endocrinol Metab 1994; 79: 76-9
32. Lahiri DK, Davis D, Adkins M, Nurnberger JI Jr. Factors that influence radioimmunoassay of plasma melatonin: a modified column procedure to eliminate interference. Biochem Med Metab Biol 1993; 49: 36-50
33. Nordern AGW, Jackson RA, Nordern LE, Griffin AJ, Barnes MA, Little JA. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin Chem 1997; 43: 957-62
34. Highton J, Hessian P. A solid phase enzyme immunoassay for C-reactive protein: clinical value and the effect of rheumatoid factor. J Immunol Methods 1984; 68: 185-92
35. Muller W, Mieraus R, Wholtman D. Interferences of rheumatoid factor with nephelometric CRP determination. J Immunol Methods 1985; 80: 77-90
36. Masson PL, Cambiaso CL, Collet-Cassant D, Magnusson CGM, Richards CB, Surdic CJM. Particle counting immunoassays. Methods Enzymol 1981; 74: 106-39
37. O'Farrelly C, Price R, McGillivray AJ, Fernandes L. IgA rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis. Immunol Invest 1989; 18: 753-64
38. Essink AW, Arkesteijn GJ, Noterman S. Interference in the sandwich enzyme-linked immunosorbent assay (ELISA). J Immunol Methods 1985; 80: 91-6
39. Zweig MH, Glickman J, Csako G. Analytical interference caused by incompletely clotted serum specimens. Clin Chem 1994; 40: 2325-6
40. Collins AM. Xenogeneric antibodies and atopic disease. Lancet 1988; i: 734-7
41. May CD, Remigio L, Feldman J, Bock SA, Carr RI. A study of serum antibodies to isolated milk proteins and ovalbumin in infants and children. Clin Allergy 1977; 7: 583-95
42. Larsson A, Wejaker PE, Forsberg PO, Lindahl T. Chicken antibodies: a tool to avoid interference from complement activation in ELISA. J Immunol Methods 1992; 153: 79-83
43. Slaats EH, Kennedy JC, Kruijswiljk H. Interference of sex-hormone binding globulin in the 'Coat-A-Count' testosterone no extraction radioimmunoassay. Clin Chem 1987; 33: 300-2
44. Masters AM, Hahnel R. Investigation of sex-hormone binding globulin interference in direct radioimmunoassays for testosterone and estradiol. Clin Chem 1989; 35: 979-84
45. Bodlaender P. No SHBG interference with the 'Coat-A-Count' total testosterone direct RIA kit. Clin Chem 1990; 36: 173
46. Luppa P, Neumeier D. Effect of sex hormone binding globulin on no-extraction immunoassays for testosterone. Clin Chem 1990; 36: 172-3
47. Refetoff S. Inherited thyroxine binding globulin abnormalities in man. Endocr Rev 1989; 10: 275-93
48. Bartalana L, Robbins J. Thyroid hormone transport proteins. Clin Lab Med 1993; 13: 583-98
49. Ekins RP. Measurement of free hormones in blood. Endocr Rev 1990; 11: 5-46
50. Nelson JC, Wilcox RB. Analytical performance of free and total thyroxine assays. Clin Chem 1996; 42: 146-54
51. Tuttlebee JW. Further experience with free thyroxine assays with particular reference to pregnancy. Ann Clin Biochem 1982; 19: 374-8
52. Reilly CP, Adamek KJ, Wellby ML. Critical assessment of the Amerlite free T4 assay. Ann Clin Biochem 1989; 26: 517-21
53. Ashwell K, Hopton MR, Harrop JS. Serum free thyroxine concentrations in subjects with high circulating levels of thyroxine binding globulin. Ann Clin Biochem 1983; 20: 285-8
54. Nishikawa M, Ogawa Y, Yoshikawa N, Yoshimura M, Toyoda N, Shouzu A, et al. Plasma free thyroxine (free T4) concentrations during haemodialysis in patients with chronic renal failure: effects of non-esterified fatty acids on free T4 measurement. Endocr J 1996; 43: 487-93
55. Midgley JEM, Sheehan CP, Christofides ND, Fry JE, Browning D, Mardell R. Concentrations of free thyroxine and albumin in severe nonthyroidal illness: assay artefacts and physiological influences. Clin Chem 1990; 36: 765-71
56. Docter R, van Toor H, Krenning EP, de Jong M, Henneman G. Free thyroxine assessed with three assays in sera of patients with non-thyroidal illness and of subjects with abnormal concentrations of thyroxine binding proteins. Clin Chem 1993; 39: 1668-74
57. Stockigt JR, Topliss DJ, Barlow JW, White EL, Hurley DM, Taft P. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. J Clin Endocrinol Metab 1981; 53: 353-9
58. Scotolinni AG, Bhagavan NV, Oshiro T, Powers L. Familial dysalbuminemic hyperthyroxinemia: a study of four probands and the kindred of three. Clin Chem 1984; 30: 1179-81
59. Henneman G, Docter R, Krenning EP, Bos G, Otten M, Visser TJ. Raised total thyroxine and free thyroxine index but normal free thyroxine. A serum abnormality due to inherited increased affinity of iodothyronines for serum binding proteins. Lancet 1979; 1: 639-42
60. Stewart FM, Ratcliffe WA, Roberts I. Thyroid function tests in patients with familial dysalbuminaemic hyperthyroxinaemia (FDH). Ann Clin Biochem 1986; 23: 59-64
61. Robbins J, Rall JE, Rawson RW. An unusual instance of thyroxine-binding by human serum gamma globulin. J Clin Endocrinol Metab 1956; 16: 573-9
62. Sakata S, Matsuda M, Ogawa T, Takuno H, Matsui I, Sarui H, et al. Prevalence of thyroid hormone autoantibodies in healthy subjects. Clin Endocrinol 1994; 41: 365-70
63. Ritter D, Brown W, Nahm MH, Ladenson JH, Scott MG. Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterisation and prevalence. Clin Chem 1994; 40: 1940-3
64. Christofedes ND, Sheehan CP, Midgley JEM. One-step, labelled antibody assay for measuring free thyroxin. I. Assay development and validation. Clin Chem 1992; 38: 11-18
65. Sheehan CP, Christofedes ND. One-step, labelled antibody assay for measuring free thyroxine II performance in a multicentre trial. Clin Chem 1992; 38: 19-25
66. Lai LC, Day JA, Clark F, Peaston RT. Spuriously high free thyroxine with the Amerlite MAB free T4 assay. J Clin Pathol 1994; 47: 181-2
67. Westerhuis LWJJM, Venekamp WJJR. Falsely high free thyroxine concentration measured with Amerlite MAB free T4. Clin Chem 1995; 41: 633-4
68. Ritter D, Brown W, Nahm MH, Ladenson JH, Scott MG. Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterisation and prevalence. Clin Chem 1994; 40: 1940-3
69. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996; 42: 164-73
70. Feldt-Rasmussen U. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin Chem 1996; 42: 160-3
71. Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32: 1491-5
72. Jeffcoate WJ, Selby C, Powell RJ. Radioimmunoassay artefact associated with circulating anti-rabbit antibodies. Clin Endocrinol 1988; 28: 39-43
73. Kuroki M, Matsumo Y, Arakawa F, Haruno M, Murakami M, Ozaki H, et al. Reducing interference from heterophilic antibodies in a two-site immunoassay for carcino-embryonic antigen (CEA) by using a human mouse chimeric antibody to CEA as the tracer. J Immunol Methods 1995; 180: 81-91
74. Hansen HJ, LaFontaine G, Newman ES, Schwartz MK, Malkin A, Mojsizik K, et al. Solving the problem of antibody interference in commercial 'sandwich'-type immunoassays of carcinoembryonic antigen. Clin Chem 1989; 35: 146-51
75. Boerman OC, Segers MFG, Poels LG, Kenemans P, Thomas CMG. Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorimetric assay. Clin Chem 1990; 36: 888-91
76. Reinsberg J, Heydweiller A, Wagner U, Pfell K, Ochr P, Krebs D. Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection. Clin Chem 1990; 36: 164-7
77. Kricka L, Schmerfeld-Pruss, Senior M, Goodman DBP, Kaladas P. Interference by human anti-mouse antibody in two-site immunoassays. Clin Chem 1990; 36: 892-4
78. Fiad TM, Duffy J, McKenna TJ. Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies. Clin Endocrinol 1994; 41: 391-5
79. Liendo C, Ghali JK, Graves SW. A new interference in some digoxin assays: anti-murine heterophilic antibodies. Clin Pharmacol Ther 1996; 60: 593-8
80. John R, Henley R, Barron N. Antibody interference in a two site immunometric assay for thyrotrophin. Ann Clin Biochem 1989; 26: 346-52
81. Madry N, Auerbach B, Schelp C. Measures to overcome HAMA interferences in immunoassays. Anticancer Res 1997; 17: 2883-6
82. Jager W, Zoller O. Human anti-mouse antibodies against OC 125 do not interfere in a CA 125 assay that uses OC 125 and M11 antibodies. Clin Chem 1993; 39: 1556-7
83. Hasholzner U, Stieber P, Meier W, Lamerz R. Value of HAMA determination in clinical practice - an overview. Anticancer Res 1997; 17: 3055-8
84. Labus JM, Petersen BH. Quantitation of human anti-mouse antibody by flow cytometry. Cytometry 1992; 13: 275-81
85. Benvenga S, Calzi LL, Robbins J. Effect of free fatty acids and nonlipid inhibitors of thyroid hormone binding in the immunoradiometric assay of thyroxine binding globulin. Clin Chem 1987; 33: 1752-5
86. Ezam E, Emmanuel A, Valente D, Grognet JM. Effect of variability of plasma interferences on the accuracy of drug immunoassays. Ther Drug Monit 1997; 19: 212-8
87. Yun WS, Ho CS, Panesar NS, Swaminathan R. The contribution of steroids to digoxin-like immunoreactivity in cord blood. Ann Clin Biochem 1992; 29: 337-42
88. Fushimi R, Yamanishi H, Inoue M, Iyama S, Amíno N. Digoxin immunoassay that avoids cross reactivity from Chinese medicines. Clin Chem 1995; 41: 621
89. Miles LE, Lipschitz DA, Beiber CP, Cook JD. Measurement of serum ferritin by a two-site immunoradiometric assay. Anal Biochem 1974; 61: 209-24
90. Rodbard D, Feldman Y, Jaffe ML, Miles LE. Kinetics of two-site immunoradiometric (sandwich) assays - II. Studies on the nature of the 'high dose hook effect'. Immunochemistry 1978; 15: 77-82
91. Kileen AA, Ramey ML, Dean JJ. High dose hook effect in immunoluminmetric thyrotropin assay: the open-faced sandwich artefact. Ann Clin Biochem 1993; 30: 413-4
92. Perera P, Worwood M. Antigen binding in the two-site immunoradiometric assay for serum ferritin: the nature of the hook effect. Ann Clin Biochem 1984; 21: 393-7
93. Ryall RG, Story CJ, Turner DR. Reappraisal of the causes of the 'hook effect' in two-site immunoradiometric assays. Anal Biochem 1982; 127: 308-15
94. Fernando SA, Sportsman JR, Wilson GS. Studies of the low dose hook effect in a competitive homogeneous immunoassay. J Immunol Methods 1992; 151: 27-46
95. Fernando SA, Wilson GS. Studies of the hook effect in the one step sandwich immunoassay. J Immunol Methods 1992; 151: 47-66
96. Fernando SA, Wilson GS. Multiple epitope interactions in the two-step sandwich immunoassay. J Immunol Methods 1992; 151: 67-86
97. Hoffman KL, Parsons GH, Allerdt LJ, Brooks JM, Miles LE. Elimination of 'hook-effect' in two-site immunoradiometric assays by kinetic rate analysis. Clin Chem 1984; 30: 1499-501
98. Frengen J, Nustad K, Schmid R, Lindmo T. A sequential binding assay with a working range extending beyond seven orders of magnitude. J Immunol Methods 1995; 178: 131-40
99. Landsteiner K. The Specificity of Serological Reactions. Boston: Harvard University Press, 1945
100. Abraham GE. Characterisation of steroid antisera. In: Cameron EHD, Hillier SG, Griffiths K, eds. Steroid Immunoassay Fifth Tenovus Workshop. Alpha and Omega Publishing, 1975: 67-78
101. Ekins RP. Immunoassay design and optimisation. In: Price CP, Newman DJ, eds. Principles and Practice of Immunoassay. New York: Stockton Press, 1991: 96-153
102. Ismail AA, Astley P, Burr WA, Cawood M, Short F, Wakelin K, et al. The role of testosterone measurements in the investigation of androgen disorders. Ann Clin Biochem 1986; 23: 113-34
103. Hill RP, Henson DB, Selby C, Saihan E, Thompson GA. Grossly elevated testosterone in three female patients: an assay artefact on the Bayer Immuno-1. In: Proceedings of the ACB National Meeting (Focus 98), Glasgow, 11-15 May 1998: Abstract 45.
104. Micallef JV, Hayes M, Latif A, Ahsan R, Sufi SB. Serum binding of steroid tracers and its possible effects on direct steroid immunoassay. Ann Clin Biochem 1995; 32: 566-74
105. Fuqua JS, Sher ES, Migeon CJ, Berkowtitz GD. Assay of plasma testosterone during the first six months of life: importance of Chromatographic purification of steroids. Clin Chem 1995; 41: 1146-9
106. Wallace AM. Analytical support for the detection and treatment of congenital adrenal hyperplasia. Ann Clin Biochem 1995; 32: 9-27
107. John R, Kadury S, Woodhead SJ, Pritchard MH. Fenclofac and thyroid function tests. Ann Clin Biochem 1983; 20: 381-2
108. Salway JG, ed. Drug Interaction Handbook. London: Chapman and Hall, 1990
109. Young DS. Effects of Drugs on Clinical Laboratory Tests, 4th edn. Washington DC: American Association for Clinical Chemistry, 1995
110. Perry B, Chapman RS, McConway MG, Griffin D, Beastall GH. Specificity of two-site immunometric assays. Ann Clin Biochem 1991; 28: 83-6
111. Morrison SL, Canfield S, Porter S, Tan LK, Tao M, Wims LA. Production and characterisation of genetically engineered antibody molecules. Clin Chem 1988; 34: 1668-75
112. Winter G, Milstein C. Man-made antibodies. Nature 1991; 349: 293-9
113. Olukoga AO, Mitchell R, Walton N, Robertson WR, Laing I. Differences in serum luteinising hormone measurements by immunoradiometric assay induced by kinetic manipulation of assay conditions are dependent on the endocrine milieu of serum. Ann Clin Biochem 1996; 33: 107-11
114. Petterson KSI, Soderholm JR. Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem 1991; 37: 333-40
115. Vermes I, Bonte HA, Sluijs Veer GvD, Schoemaker J. Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalisation with WHO standard. Clin Chem 1991; 37: 415-21
116. Demers LM. Monoclonal antibodies to lutropin: are our immunoassays too specific? Clin Chem 1991; 37: 311-2
117. Fineo B, Bizzaro N, Scomparin D. Pitfalls in measuring lutropin by two-site immunoassay with monoclonal antibodies against the intact molecule. Clin Chem 1992; 38: 2159-60
118. Smith KA, McConway MG, Perry B, Chapman RS, Beastall GH. Discrepancies in hFSH measurement by two site IRMA in the ovulatory phase of the menstrual cycle. Ann Clin Biochem 1992; 29: 351-3
119. Kardana A, Cole LA. Polypeptide nicks cause erroneous results in assays of human chorionic gonadotrophin free β-subunit. Clin Chem 1992; 38: 26-3
120. Wood PJ. The measurement of parathyroid hormone. Ann Clin Biochem 1992; 29: 11-21